Health
FDA cleared novel mitochondrial therapy for Bill Ackman's daughter, report says
Slashdot reports that Bill Ackman pledged over $400 million for longevity research following emergency treatment for his daughter.
The short version
- Lucy Ackman suffered a brain hemorrhage in February that left her unable to move, speak, or see.[Slashdot]
- The FDA granted an emergency authorization in May to transplant mitochondria from her leg muscle to her eyes.[Slashdot]
- Billionaire investor Bill Ackman pledged over $400 million to establish an institute dedicated to longevity and brain health.[Slashdot]
Key facts
- Lucy Ackman was left unable to speak, move, or see after suffering a brain hemorrhage in February.[Slashdot]
- In May, the FDA granted an emergency authorization permitting clinicians to transfer mitochondria from her leg to her eyes.[Slashdot]
- Bill Ackman committed over $400 million to create a research institute focused on brain health and longevity.[Slashdot]
What remains uncertain
- The clinical outcome and long-term efficacy of the experimental mitochondrial transplant have not been reported.[Slashdot]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.